Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology

PLoS Pathogens

Volumn 12, Issue 1, 2016, Pages

  Montes de Oca, Marcela ^a,b   Kumar, Rajiv ^a,c   de Labastida Rivera, Fabian ^a   Amante, Fiona H ^a   Sheel, Meru ^a   Faleiro, Rebecca J ^a,d   Bunn, Patrick T ^a,e   Best, Shannon E ^a   Beattie, Lynette ^a   Ng, Susanna S ^a,e   Edwards, Chelsea L ^a,b   Muller, Werner ^f   Cretney, Erika ^g,h   Nutt, Stephen L ^g,h   Smyth, Mark J ^a   Haque, Ashraful ^a   Hill, Geoffrey R ^a   Sundar, Shyam ⁱ   Kallies, Axel ^g,h   Engwerda, Christian R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NETAJI SUBHAS INSTITUTE OF TECHNOLOGY   (India)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e GRIFFITH UNIVERSITY   (Australia)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR; PRDM1 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL SIGNALING ASSAY; CYTOKINE PRODUCTION; DNA SYNTHESIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNE RESPONSE; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PLASMODIUM CHABAUDI INFECTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLENOMEGALY; TISSUE INJURY; VISCERAL LEISHMANIASIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; HUMAN; IMMUNOLOGY; INFLAMMATION; MALARIA; MALE; MUTANT MOUSE STRAIN; PATHOLOGY; TH1 CELL;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERLEUKIN-10; LEISHMANIASIS, VISCERAL; MALARIA; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROSCOPY, FLUORESCENCE; REPRESSOR PROTEINS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84956808926     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005398     Document Type: Article

References (90)

1. Kruglov AA, Kuchmiy A, Grivennikov SI, Tumanov AV, Kuprash DV, et al. (2008) Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models. Cytokine Growth Factor Rev 19: 231–244. doi: 10.1016/j.cytogfr.2008.04.010 18502680
2. Beutler B, Milsark IW, Cerami AC, (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869–871. 3895437
3. Monaco C, Nanchahal J, Taylor P, Feldmann M, (2015) Anti-TNF therapy: past, present and future. Int Immunol 27: 55–62. doi: 10.1093/intimm/dxu102 25411043
4. Feldmann M, Maini RN, (2001) Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19: 163–196. 11244034
5. Crawford M, Curtis JR, (2008) Tumor necrosis factor inhibitors and infection complications. Curr Rheumatol Rep 10: 383–389. 18817643
6. Kim SY, Solomon DH, (2010) Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol 6: 165–174. doi: 10.1038/nrrheum.2009.279 20142812
7. Sher A, Coffman RL, (1992) Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 10: 385–409. 1590992
8. Zhu J, Yamane H, Paul WE, (2010) Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28: 445–489. doi: 10.1146/annurev-immunol-030409-101212 20192806
9. O'Garra A, Murphy KM, (2009) From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development. Nat Immunol 10: 929–932. doi: 10.1038/ni0909-929 19692989
10. Tubo NJ, Jenkins MK, (2014) CD4+ T Cells: guardians of the phagosome. Clin Microbiol Rev 27: 200–213. doi: 10.1128/CMR.00097-13 24696433
11. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T cells and immune tolerance. Cell 133: 775–787. doi: 10.1016/j.cell.2008.05.009 18510923
12. Saraiva M, O'Garra A, (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170–181. doi: 10.1038/nri2711 20154735
13. Fiorentino DF, Bond MW, Mosmann TR, (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081–2095. 2531194
14. Yssel H, De Waal Malefyt R, Roncarolo MG, Abrams JS, Lahesmaa R, et al. (1992) IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 149: 2378–2384. 1356125
15. Meyaard L, Hovenkamp E, Otto SA, Miedema F, (1996) IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 156: 2776–2782. 8609396
16. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737–742. 9338786
17. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F, (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190: 995–1004. 10510089
18. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, et al. (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546–558. doi: 10.1016/j.immuni.2008.02.017 18387831
19. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, et al. (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8: 1363–1371. 17994025
20. Stager S, Maroof A, Zubairi S, Sanos SL, Kopf M, et al. (2006) Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur J Immunol 36: 1764–1771. 16791879
21. Anderson CF, Oukka M, Kuchroo VJ, Sacks D, (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204: 285–297. 17283207
22. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, et al. (2008) IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 4: e1000004. doi: 10.1371/journal.ppat.1000004 18401464
23. Freitas do Rosario AP, Lamb T, Spence P, Stephens R, Lang A, et al. (2012) IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol 188: 1178–1190. doi: 10.4049/jimmunol.1102755 22205023
24. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, et al. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273–283. 17283209
25. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA, (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63–74. 16005735
26. Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, et al. (1994) IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol 153: 3135–3140. 8089491
27. Roffe E, Rothfuchs AG, Santiago HC, Marino AP, Ribeiro-Gomes FL, et al. (2012) IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J Immunol 188: 649–660. doi: 10.4049/jimmunol.1003845 22156594
28. Namangala B, Noel W, De Baetselier P, Brys L, Beschin A, (2001) Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J Infect Dis 183: 1794–1800. 11372033
29. Nylen S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, et al. (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204: 805–817. 17389235
30. Jagannathan P, Eccles-James I, Bowen K, Nankya F, Auma A, et al. (2014) IFNgamma/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog 10: e1003864. doi: 10.1371/journal.ppat.1003864 24415936
31. Portugal S, Moebius J, Skinner J, Doumbo S, Doumtabe D, et al. (2014) Exposure-dependent control of malaria-induced inflammation in children. PLoS Pathog 10: e1004079. doi: 10.1371/journal.ppat.1004079 24743880
32. Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, et al. (2009) Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog 5: e1000364. doi: 10.1371/journal.ppat.1000364 19343213
33. Hunter CA, Kastelein R, (2012) Interleukin-27: balancing protective and pathological immunity. Immunity 37: 960–969. doi: 10.1016/j.immuni.2012.11.003 23244718
34. Engwerda CR, Ng SS, Bunn PT, (2014) The Regulation of CD4(+) T Cell Responses during Protozoan Infections. Front Immunol 5: 498. doi: 10.3389/fimmu.2014.00498 25352846
35. Roncarolo MG, Gregori S, Bacchetta R, Battaglia M, (2014) Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol 380: 39–68. doi: 10.1007/978-3-662-43492-5_3 25004813
36. Whiteside TL, Schuler P, Schilling B, (2012) Induced and natural regulatory T cells in human cancer. Expert Opin Biol Ther 12: 1383–1397. doi: 10.1517/14712598.2012.707184 22849383
37. Junt T, Scandella E, Ludewig B, (2008) Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat Rev Immunol 8: 764–775. doi: 10.1038/nri2414 18825130
38. Mebius RE, Kraal G, (2005) Structure and function of the spleen. Nat Rev Immunol 5: 606–616. 16056254
39. Forster R, Davalos-Misslitz AC, Rot A, (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8: 362–371. doi: 10.1038/nri2297 18379575
40. Boelaert M, Sundar S, Farrer J, Hotez PJ, Junghanss T, Kang G, Lalloo D, (2014) Leishmaniasis. In: et al., editors. Manson's Tropical Diseases. Amsterdam: Elsevier. pp. 631–651.
41. White N, Farrer J, Hotez PJ, Junghanss T, Kang G, Lalloo D, (2014) Malaria. In: et al., editors. Malaria. Amsterdam: Elsevier. pp. 532–601.
42. Achtman AH, Khan M, MacLennan IC, Langhorne J, (2003) Plasmodium chabaudi chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J Immunol 171: 317–324. 12817013
43. Dalton JE, Glover AC, Hoodless L, Lim EK, Beattie L, et al. (2015) The neurotrophic receptor Ntrk2 directs lymphoid tissue neovascularization during Leishmania donovani infection. PLoS Pathog 11: e1004681. doi: 10.1371/journal.ppat.1004681 25710496
44. Dalton JE, Maroof A, Owens BM, Narang P, Johnson K, et al. (2010) Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice. J Clin Invest 120: 1204–1216. doi: 10.1172/JCI41281 20234089
45. Helmby H, Jonsson G, Troye-Blomberg M, (2000) Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. Infect Immun 68: 1485–1490. 10678964
46. Smelt SC, Engwerda CR, McCrossen M, Kaye PM, (1997) Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol 158: 3813–3821. 9103448
47. Veress B, Omer A, Satir AA, El Hassan AM, (1977) Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology 33: 605–610. 590992
48. Zijlstra EE, el-Hassan AM, (2001) Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95 Suppl 1: S27–58. 11370250
49. Keenan CM, Hendricks LD, Lightner L, Johnson AJ, (1984) Visceral leishmaniasis in the German shepherd dog. II. Pathology. Vet Pathol 21: 80–86. 6710817
50. Ato M, Stager S, Engwerda CR, Kaye PM, (2002) Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol 3: 1185–1191. 12436111
51. Engwerda C, Ato M, Cotterell S, Mynott T, Tschannerl A, et al. (2002) A Role for tumor necrosis factor-α in remodeling the splenic marginal zone during Leishmania donovani infection. The American Journal of Pathology 161: 429–437. 12163368
52. Heinemann C, Heink S, Petermann F, Vasanthakumar A, Rothhammer V, et al. (2014) IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1. Nat Commun 5: 3770. doi: 10.1038/ncomms4770 24796719
53. Neumann C, Heinrich F, Neumann K, Junghans V, Mashreghi MF, et al. (2014) Role of Blimp-1 in programing Th effector cells into IL-10 producers. J Exp Med 211: 1807–1819. doi: 10.1084/jem.20131548 25073792
54. Kallies A, Xin A, Belz GT, Nutt SL, (2009) Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 31: 283–295. doi: 10.1016/j.immuni.2009.06.021 19664942
55. Kallies A, Hasbold J, Tarlinton DM, Dietrich W, Corcoran LM, et al. (2004) Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J Exp Med 200: 967–977. 15492122
56. Ansari NA, Kumar R, Gautam S, Nylen S, Singh OP, et al. (2011) IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol 186: 3977–3985. doi: 10.4049/jimmunol.1003588 21357266
57. Engwerda CR, Kaye PM, (2000) Organ-specific immune responses associated with infectious disease. Immunol Today 21: 73–78. 10652464
58. Salehi S, Bankoti R, Benevides L, Willen J, Couse M, et al. (2012) B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4+ T cells. J Immunol 189: 5682–5693. doi: 10.4049/jimmunol.1201966 23162130
59. Roers A, Siewe L, Strittmatter E, Deckert M, Schluter D, et al. (2004) T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J Exp Med 200: 1289–1297. 15534372
60. O'Garra A, Vieira PL, Vieira P, Goldfeld AE, (2004) IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114: 1372–1378. 15545984
61. Pils MC, Pisano F, Fasnacht N, Heinrich JM, Groebe L, et al. (2010) Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur J Immunol 40: 443–448. doi: 10.1002/eji.200939592 19941312
62. Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW, (2000) Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 68: 6289–6293. 11035737
63. Taylor AP, Murray HW, (1997) Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. J Exp Med 185: 1231–1239. 9104810
64. Cretney E, Xin A, Shi W, Minnich M, Masson F, et al. (2011) The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol 12: 304–311. doi: 10.1038/ni.2006 21378976
65. Kallies A, Hawkins ED, Belz GT, Metcalf D, Hommel M, et al. (2006) Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol 7: 466–474. 16565720
66. Martins GA, Cimmino L, Shapiro-Shelef M, Szabolcs M, Herron A, et al. (2006) Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 7: 457–465. 16565721
67. Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, et al. (2009) Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325: 1006–1010. doi: 10.1126/science.1175870 19608860
68. Findlay EG, Greig R, Stumhofer JS, Hafalla JC, de Souza JB, et al. (2010) Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J Immunol 185: 2482–2492. doi: 10.4049/jimmunol.0904019 20631310
69. Anderson CF, Stumhofer JS, Hunter CA, Sacks D, (2009) IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J Immunol 183: 4619–4627. doi: 10.4049/jimmunol.0804024 19748991
70. Melero I, Grimaldi AM, Perez-Gracia JL, Ascierto PA, (2013) Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination. Clin Cancer Res 19: 997–1008. doi: 10.1158/1078-0432.CCR-12-2214 23460531
71. Kraal G, (1992) Cells in the marginal zone of the spleen. Int Rev Cytol 132: 31–74. 1555921
72. Kraal G, Rodrigues H, Hoeben K, Van Rooijen N, (1989) Lymphocyte migration in the spleen: the effect of macrophage elimination. Immunology 68: 227–232. 2807380
73. Lyons AB, Parish CR, (1995) Are murine marginal-zone macrophages the splenic white pulp analog of high endothelial venules? Eur J Immunol 25: 3165–3172. 7489759
74. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, et al. (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329: 630–632. 2443857
75. Baluk P, Yao LC, Feng J, Romano T, Jung SS, et al. (2009) TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 119: 2954–2964. doi: 10.1172/JCI37626 19759514
76. Szekanecz Z, Gaspar L, Koch AE, (2005) Angiogenesis in rheumatoid arthritis. Front Biosci 10: 1739–1753. 15769663
77. Engwerda CR, Ato M, Stager S, Alexander CE, Stanley AC, et al. (2004) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 165: 2123–2133. 15579454
78. Brenner D, Blaser H, Mak TW, (2015) Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol 15: 362–374. doi: 10.1038/nri3834 26008591
79. Dahlen R, Strid H, Lundgren A, Isaksson S, Raghavan S, et al. (2013) Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis. Scand J Immunol 78: 275–284. doi: 10.1111/sji.12081 23713660
80. Schmaltz C, Alpdogan O, Muriglan SJ, Kappel BJ, Rotolo JA, et al. (2003) Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 101: 2440–2445. 12424195
81. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, et al. (1997) Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90: 3204–3213. 9376604
82. Hippen KL, Riley JL, June CH, Blazar BR, (2011) Clinical perspectives for regulatory T cells in transplantation tolerance. Semin Immunol 23: 462–468. doi: 10.1016/j.smim.2011.07.008 21820917
83. Miyara M, Ito Y, Sakaguchi S, (2014) TREG-cell therapies for autoimmune rheumatic diseases. Nat Rev Rheumatol 10: 543–551. doi: 10.1038/nrrheum.2014.105 24980140
84. Adeegbe DO, Nishikawa H, (2013) Natural and induced T regulatory cells in cancer. Front Immunol 4: 190. doi: 10.3389/fimmu.2013.00190 23874336
85. Liston A, Gray DH, (2014) Homeostatic control of regulatory T cell diversity. Nat Rev Immunol 14: 154–165. doi: 10.1038/nri3605 24481337
86. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, et al. (2003) CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197: 111–119. 12515818
87. Franke-Fayard B, Janse CJ, Cunha-Rodrigues M, Ramesar J, Buscher P, et al. (2005) Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A 102: 11468–11473. 16051702
88. Amante FH, Stanley AC, Randall LM, Zhou Y, Haque A, et al. (2007) A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol 171: 548–559. 17600128
89. Amante FH, Haque A, Stanley AC, Rivera Fde L, Randall LM, et al. (2010) Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol 185: 3632–3642. doi: 10.4049/jimmunol.1000944 20720206
90. Haque A, Best SE, Unosson K, Amante FH, de Labastida F, et al. (2011) Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J Immunol 186: 6148–6156. doi: 10.4049/jimmunol.1003955 21525386